Atlas Trials

Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)

Clinical trial NCT01122615 · COMPLETED

Trial details

NCT number
NCT01122615
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell CancerKidney Cancer
Start date
2010-05-01
Primary completion
2014-07-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.